← FDA Drug Approvals (Drugs@FDA)
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-12-19
Drug application
- FDA Application #
ANDA206180- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
- Generic name
- AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE
- Active ingredients
- AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2017-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown